Background: Individuals with Down Syndrome (DS) exhibit a unique aging profile and have early-onset Alzheimer's Disease (AD) due to a triplication of the amyloid precursor protein (APP) gene on chromosome 21.

Method: Here, we present a study of a 73-year-old non-Hispanic White female with DS who underwent extensive clinical assessments for several decades. She had a cognitive and functional impairment consistent with DS and AD-like symptoms. Post-autopsy we did neuropathological and immunohistochemical analysis of the brain and retina.

Result: Neuropathological and immunohistochemical analysis of the brain and retina revealed age and disease-related changes. Numerous senile plaques, neurofibrillary tangles, Lewy bodies, and cerebral amyloid angiopathy were found throughout cortical and subcortical regions of the brain. Additionally, aberrant TAR DNA-protein (TDP) 43 accumulation was observed in the amygdala and hippocampus. Immunofluorescent analysis of retinal tissue revealed the presence of amyloid deposits and phosphorylated tau in the ganglion cell and inner plexiform layer of the retina. Whole-genome sequencing identified two SNPs, rs2802292 and rs4977756 (p < 0.05), linked to longer lifespans.

Conclusion: This case report provides a comprehensive look into the clinical and neuropathological correlates of DS and documents unique clinical and pathological changes over 7 decades of life. We also explored hypotheses and potential mechanisms underlying increased lifespan in certain DS individuals despite progressive intellectual impairment and neurodegenerative pathologies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.092874DOI Listing

Publication Analysis

Top Keywords

neuropathological immunohistochemical
8
immunohistochemical analysis
8
analysis brain
8
basic science
4
science pathogenesis
4
pathogenesis background
4
background individuals
4
individuals syndrome
4
syndrome exhibit
4
exhibit unique
4

Similar Publications

Background: Severe systemic infections can trigger cognitive decline, but the underlying mechanisms and their impact on the manifestation and progression of Alzheimer's disease and other neurodegenerative diseases are poorly understood. The current COVID-19 pandemic has brought a surge of severe viral illness and highlights the importance of understanding the impact of acute infections on cognition and the manifestation of neurodegenerative disease in survivors. A wealth of observational and clinical data suggests major short- and long-term effects of severe infections on cognition, but detailed and systematic analyses of neuropathological changes after acute infections are scarce.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA.

Background: Lewy bodies (LBs), characterized by intraneuronal inclusions of misfolded alpha-synuclein (α-syn) protein, are the pathological hallmark of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Because this protein is phosphorylated at serine-129 in 90% of LBs, its phosphorylation is considered a crucial pathogenic event in LB formation and disease development. Here, we present a unique brain autopsy case of a DLB patient with widespread LBs that were negative for phosphorylated-α-syn, challenging traditional diagnostic criteria.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Mayo Clinic, Jacksonville, FL, USA.

Background: Posttranslational modifications of tau occurs throughout disease progression in Alzheimer's disease (AD) and non-AD tauopathies. Phosphorylation of tau (p-tau) in the proline-rich region is a common target of immunohistochemical and fluid biomarker evaluation. P-tau217 has emerged as a highly accurate fluid biomarker in AD, however elevated levels are not observed in non-AD tauopathies.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Dementia and Neurodegenerative Disease Research Center, Inje University, St Charles, Korea, Republic of (South); Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea, Republic of (South); Inje University College of Medicine, BUSAN, Korea, Republic of (South).

Background: Because of clinically overlapping parkinsonian motor symptoms, it is hard to diagnose a specific disease in atypical parkinsonism or differentiate Parkinson's disease (PD) from atypical parkinsonism. Herein, we report the clinicopathological mismatching of an autopsy-confirmed PSP in a patient clinically diagnosed with PD.

Method Clinical History: We reviewed the brief clinical history of a 70-year-old man and neurologic examination.

View Article and Find Full Text PDF

Background: Individuals with Down Syndrome (DS) exhibit a unique aging profile and have early-onset Alzheimer's Disease (AD) due to a triplication of the amyloid precursor protein (APP) gene on chromosome 21.

Method: Here, we present a study of a 73-year-old non-Hispanic White female with DS who underwent extensive clinical assessments for several decades. She had a cognitive and functional impairment consistent with DS and AD-like symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!